NEPHROCARE HEALTH SERV L (NEPHROPLUS) Price Target & Share Price Forecast
Not a guess. A distribution.
As of , the NEPHROCARE HEALTH SERV L (NEPHROPLUS) 1-year price target is ₹1,624 — +121.3% from the current price of ₹734. The 80% confidence range is ₹910–₹2,918, with a 96.0% probability of finishing above today's price.
Probability-weighted price target and forecast for NEPHROCARE HEALTH SERV L (NEPHROPLUS) across 2027, 2029, and 2031. Built from a 10,000-trial Monte Carlo simulation on 0.5 years of NSE historical data — so you see the full range of where the price could realistically land, weighted by likelihood. No analyst opinions. Just statistics.
NEPHROPLUS price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds NEPHROPLUS hits common targets within the simulated horizon?
How the NEPHROPLUS price target & forecast are calculated
We ran 10,000 simulated price paths for NEPHROCARE HEALTH SERV L (NEPHROPLUS) using Geometric Brownian Motion (GBM) — the same probability framework used in institutional risk-management systems. The simulation uses NEPHROPLUS's actual 0.5-year historical volatility (45.1%) and mean log return (90.0%/year), so it reflects real market behaviour, not assumptions.
Each of the 10,000 trials projects a unique NEPHROPLUS share price path day-by-day for 5 years. The percentile bands (P10/P50/P90) show the full distribution of outcomes — your real price target range, not a single guess.
Why this NEPHROPLUS forecast differs from analyst price targets: Analyst targets are point estimates from subjective valuation models. Monte Carlo price-target forecasts are probability distributions from actual market data. They tell you the range and likelihood of where NEPHROPLUS could realistically land — so you can plan for the spread of outcomes, not bet on a wish.
NEPHROPLUS price target & forecast — probability table
| Horizon | Pessimistic (P10) | Median (P50) | Optimistic (P90) | P(↑ from today) | P(2× return) |
|---|---|---|---|---|---|
| 1 year (2027) | ₹910 | ₹1,624 | ₹2,918 | 96.0% | 59.3% |
| 3 years (2029) | ₹3,037 | ₹8,043 | ₹22,009 | 99.9% | 98.5% |
| 5 years (2031) | ₹11,037 | ₹39,084 | ₹1,42,949 | 100.0% | 99.9% |
Generated 22/6/2026, 8:22:17 pm. Refreshed every 6 hours from 0.5y of NSE history.
NEPHROPLUS price target & forecast — FAQs
What is the NEPHROCARE HEALTH SERV L (NEPHROPLUS) price target / share price forecast for 2031?
Based on a 10,000-trial Monte Carlo simulation using historical volatility, NEPHROPLUS's 5-year median (P50) forecast is ₹39,084. The 80% confidence band is ₹11,037–₹1,42,949. The probability of the price being above today's ₹734 in 5 years is 100.0%.
How is Monte Carlo different from analyst price targets?
Analyst targets are point estimates based on subjective valuation models. Monte Carlo simulations produce a probability distribution from actual historical volatility — showing the full range of where the price could realistically land, weighted by likelihood. No opinions, just statistics.
Can NEPHROPLUS double in 5 years?
The probability of NEPHROPLUS reaching 2× the current price (₹1,468) within 5 years is 99.9%, based on this simulation.
Is this prediction accurate?
No simulation can predict the future — but Monte Carlo gives you a calibrated range of outcomes weighted by historical probability. It accounts for volatility better than any single price target. Use it as a decision-support tool, not a guarantee.
How often is this forecast updated?
Every 6 hours, based on the latest NSE close prices and 0.5 years of historical data.